Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

Mario Boccadoro email, Gareth Morgan email and Jamie Cavenagh email

Cancer Cell International 2005, 5:18doi:10.1186/1475-2867-5-18

No comments have yet been made on this article

Post a comment


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.